OR WAIT 15 SECS
For the third time in a row, doctors named New York-based Pfizer Inc. the most esteemed pharmaceutical company, according to Newtown, PA-based Scott-Levin.
For the third time in a row, doctors named New York-based Pfizer Inc. the most esteemed pharmaceutical company, according to Newtown, PA-based Scott-Levin's "Pharmaceutical Company Image 2002" study. Whitehouse Station, NJ-based Merck & Co. Inc. ranked second, also for the third consecutive time. Rounding out the top ten most esteemed companies (in alphabetical order) were: Wilmington, DE-based AstraZeneca LP; Bridgewater, NJ-based Aventis Pharma AG; New York-based Bristol-Myers Squibb Co.; Indianapolis-based Eli Lilly and Co.; Research Triangle Park, NC-based GlaxoSmithKline; New Brunswick, NJ-based Johnson & Johnson; East Hanover, NJ-based Novartis Pharmaceuticals Corp.; and Collegeville, PA-based Wyeth Pharmaceuticals.
As part of the survey, doctors were also asked about their opinions on a number of general issues related to the pharmaceutical industry's image. Some highlights:
•Â Overall support for the industry edged up again among physicians this year. When asked about their overall opinion of the industry, 64% of doctors indicated their feelings were "positive" or "extremely positive." In 2000, 62% of physicians felt this way; 57% felt this way in 1998.
•Â E-detailing is not yet having a significant impact on industry image, with most respondents lacking experience with this kind of promotion.
•Â A significant number of physicians continue to dislike direct-to-consumer advertising. Forty-six percent of doctors indicated that DTC promotion negatively affected their impression of companies that sponsor such activity.
•Â Reaction to prescription drug discount card programs was broadly positive. About 53% of physicians said such programs had a positive effect on the image of companies sponsoring them.
•Â The more prescriptions written, sales reps seen or patients seen per week, the more likely a physician was to have a positive overall opinion of the industry.
•Â Among specialists, the highest industry ratings in 2002 came from neurologists, dermatologists and oncologists.
Results of the study are based on responses from more than 7,000 physicians in 27 specialties. PR